These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3058873)

  • 1. Evaluating quality and quantity of life in breast cancer adjuvant trials.
    Fetting JH
    J Clin Oncol; 1988 Dec; 6(12):1795-7. PubMed ID: 3058873
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group).
    Gelber RD; Goldhirsch A; Hürny C; Bernhard J; Simes RJ
    J Natl Cancer Inst Monogr; 1992; (11):127-35. PubMed ID: 1385719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life during treatment in young women with breast cancer.
    Muñoz M
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():75-7. PubMed ID: 20711657
    [No Abstract]   [Full Text] [Related]  

  • 4. One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy.
    Henry NL; Stearns V
    Breast Cancer Res Treat; 2011 Feb; 125(3):751-3. PubMed ID: 20941540
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials. Referral resource. Clinical trials assessing quality of life.
    Cheson BD; McCabe MS; Phillips PH
    Oncology (Williston Park); 1995 Nov; 9(11):1171-4, 1176, 1178. PubMed ID: 8703685
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?
    Goodwin PJ
    J Clin Oncol; 2003 Dec; 21(24):4474-5. PubMed ID: 14610047
    [No Abstract]   [Full Text] [Related]  

  • 9. How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.
    Gelber RD; Cole BF; Goldhirsch A
    Recent Results Cancer Res; 1993; 127():221-33. PubMed ID: 8502819
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life in stage II breast cancer: an instrument for clinical trials.
    Levine MN; Guyatt GH; Gent M; De Pauw S; Goodyear MD; Hryniuk WM; Arnold A; Findlay B; Skillings JR; Bramwell VH
    J Clin Oncol; 1988 Dec; 6(12):1798-810. PubMed ID: 3058874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.
    Ravdin PM
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy.
    Tubiana-Hulin M; Gardner M
    Cancer Treat Res; 2009; 151():121-37. PubMed ID: 19593510
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness and other assessments of adjuvant therapies for early breast cancer.
    Hillner BE; Smith TJ
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):129-34. PubMed ID: 8608043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of life quality in cancer patients undergoing chemotherapy.
    Edelstyn GA; MacRae KD; MacDonald FM
    Clin Oncol; 1979 Mar; 5(1):43-9. PubMed ID: 369755
    [No Abstract]   [Full Text] [Related]  

  • 17. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mitoxantrone in the treatment of breast cancer.
    Hainsworth JD
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):17-20. PubMed ID: 7863347
    [No Abstract]   [Full Text] [Related]  

  • 19. A quality-of-life-oriented endpoint for comparing therapies.
    Gelber RD; Gelman RS; Goldhirsch A
    Biometrics; 1989 Sep; 45(3):781-95. PubMed ID: 2790121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating neoadjuvant chemotherapy in breast cancer.
    Lawrence G; Crawford J; Sherman F
    J Clin Oncol; 2002 Jun; 20(12):2905-6; author reply 2906-7. PubMed ID: 12065569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.